Search Results

• • 15 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?

  Authors:Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, and Vikas P SukhatmeFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20152,127 words Report 1620LAuthor(s): Pan Pantziarka [*] aff1 aff2 , Gauthier Bouche aff1 , Lydie Meheus aff1 , Vidula Sukhatme aff3 , Vikas P Sukhatme aff3 aff4 KEYWORDS drug repurposing; health economics; health policy; off-label drugs;...

• Para-aortic nodal metastases in cervical cancer: a blind spot in the International Federation of Gynecology and Obstetrics staging system: current diagnosis and management

  Authors:Lindsay Hwang, April Bailey, Jayanthi Lea, and Kevin AlbuquerqueFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20158,636 words Report 1810LAuthor(s): Lindsay Hwang aff1 , April Bailey aff2 , Jayanthi Lea aff3 , Kevin Albuquerque [*] aff1 KEYWORDS extended field radiation; locally advanced cervical cancer; para-aortic nodal metastases Carcinoma of...

• Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile

  Authors:Luciane Tsukamoto Kagohara, Juliana L Schussel, Tejaswini Subbannayya, Nandini Sahasrabuddhe, Cynthia Lebron, Mariana Brait, et al.From:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 201510,091 words Report 1760LAuthor(s): Luciane Tsukamoto Kagohara aff1 , Juliana L Schussel aff1 aff2 , Tejaswini Subbannayya aff3 , Nandini Sahasrabuddhe aff3 , Cynthia Lebron aff1 , Mariana Brait aff1 , Leonel Maldonado aff1 , Blanca L. Valle...

• Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data

  Authors:Toma&scaron Pikus, Petra Pokorna, Rostislav Vyzula, and Jana PrausovaFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20154,068 words Report 1690LAuthor(s): Katerina Kubáčková [*] aff1 aff2 , Zbyněk Bortlíček aff3 , Tomáš Pikus aff1 aff2 , Zdeněk Linke aff1 aff2 , Petra Pokorná aff1 aff2 , Rostislav Vyzula aff4 , Jana Prausová...

• Does patient education work in breast cancer? Final results from the global CARIATIDE study

  Authors:Christos Markopoulos, Patrick Neven, Minna Tanner, Michael Marty, Rolf Kreienberg, Louise Atkins, et al.From:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20157,204 words Report 1570LAuthor(s): Christos Markopoulos [*] aff1 , Patrick Neven aff2 , Minna Tanner aff3 , Michael Marty aff4 , Rolf Kreienberg aff5 , Louise Atkins aff6 , Ann Franquet aff7 , Michael Gnant aff8 , Silvia Neciosup aff9 , Petra...

• Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome

  Authors:Samuel O Ogunbiyi, Sooyoung Lee, John Mathew, and Kwok Leung CheungFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20153,933 words Report 1700LAuthor(s): Samuel O Ogunbiyi aff1 , Sooyoung Lee aff1 , John Mathew aff1 , Kwok Leung Cheung [*] aff1 KEYWORDS elderly woman; histological type; outcome; primary breast cancer The incidence of breast cancer...

• Vitronectin silencing inhibits hepatocellular carcinoma in vitro and in vivo

  Authors:Wei Zhu, Wenxue Li, Guangyu Yang, Chuanxi Fu, Gaofeng Jiang, and Qiansheng HuFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20153,929 words Report 1390LAuthor(s): Wei Zhu [*] aff1 aff2 , Wenxue Li aff1 , Guangyu Yang aff1 , Chuanxi Fu aff1 , Gaofeng Jiang aff3 , Qiansheng Hu aff2 KEYWORDS colony formation; hepatocellular carcinoma; mouse xenografts; siRNA;...

• miR-214: a potential biomarker and therapeutic for different cancers

  Authors:Tanu Sharma, Ryan Hamilton, and Chandi C MandalFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 201510,585 words Report 2280LAuthor(s): Tanu Sharma aff1 , Ryan Hamilton aff2 aff3 , Chandi C Mandal [*] aff1 KEYWORDS biomarker; miRNAs; miR-214; oncogenes; tumor suppressor miRNAs (miRs) are small approximately 22-24 nucleotide long...

• Environmental (nongenetic) factors in gynecological cancers: update and future perspectives

  Author:Penelope M WebbFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 201510,437 words Report 2330LAuthor(s): Penelope M Webb [*] KEYWORDS endometrial cancer; etiology; gynecological cancer; ovarian cancer; risk factors; survival Worldwide, more than one million women are diagnosed with cancers of the female...

• Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer

  Authors:Elisa Borso, Giuseppe Boni, Luca Galli, Sergio Ricci, Azzurra Farnesi, Sara Mazzarri, et al.From:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20155,713 words Report 1900LAuthor(s): Elisa Borsò [*] aff1 , Giuseppe Boni aff1 , Luca Galli aff2 , Sergio Ricci aff3 , Azzurra Farnesi aff2 , Sara Mazzarri aff1 , Claudia Cianci aff2 , Giuliano Mariani aff1 , Alfredo Falcone aff2 KEYWORDS...

• Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study

  Authors:Mimma Rizzo, Gaetano Facchini, Clementina Savastano, Giuseppe Di Lorenzo, Luigi De Lucia, Luigi Maiorino, et al.From:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20153,229 words Report 1520LAuthor(s): Mimma Rizzo [*] aff1 aff2 , Gaetano Facchini aff2 aff3 , Clementina Savastano aff2 aff3 , Giuseppe Di Lorenzo aff2 aff4 , Luigi De Lucia aff2 aff5 , Luigi Maiorino aff2 aff6 , Beniamino Casale aff2 aff7 ,...

• Focus on maintenance therapy in non-small-cell lung cancer

  Author:Alfredo TartaroneFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20152,020 words Report 1610LAuthor(s): Alfredo Tartarone [*] KEYWORDS maintenance therapy; non-small-cell lung cancer; pemetrexed A major area of controversy in the management of advanced non-small-cell lung cancer (NSCLC) is the role of...

• Evolution of targeted therapies in cancer: opportunities and challenges in the clinic

  Authors:Sam Santhosh, Prasanna Kumar, Vedam Ramprasad, and Amitabha ChaudhuriFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 201510,321 words Report 1870LAuthor(s): Sam Santhosh aff1 , Prasanna Kumar aff1 , Vedam Ramprasad aff1 , Amitabha Chaudhuri [*] aff1 KEYWORDS cancer; drug resistance; genetic alterations; targeted therapies Cancer is a genetic disease that...

• Epigenetic alterations in cancer and personalized cancer treatment

  Authors:Monica Miozzo, Valentina Vaira, and Silvia Maria SirchiaFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 201511,898 words Report 1840LAuthor(s): Monica Miozzo [*] aff1 aff2 , Valentina Vaira aff1 aff3 , Silvia Maria Sirchia aff4 KEYWORDS bioactive nutrients; cancer epigenetics; chemoprevention; DNA methylation; epigenetic drugs; epigenetic...

• RNA interference in the clinics: where are we standing now?

  Authors:Rishi Wagle, Masahisa Ohtsuka, Hui Ling, and Martin PichlerFrom:Future Oncology (Vol. 11, Issue 2) Peer-Reviewed

  Jan. 20151,414 words Article 1730LAuthor(s): Rishi Wagle aff1 , Masahisa Ohtsuka aff1 , Hui Ling aff1 , Martin Pichler [*] aff1 KEYWORDS cancer; efficacy; RNA interference; safety; therapy Over the last decade, the field of cancer therapy and...